Pursuant to regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has informed that the Board of Directors of the Company has appointed Meena Ganesh (DIN: 00528252) as an Additional Independent Director of the Company, with effect from March 8, 2019 for a period of 5 years. The appointment of Meena Ganesh will be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company. Brief profile: Meena Ganesh does not hold any shares in the Company. None of the Directors are related to Meena Ganesh. Meena Ganesh is not debarred or disqualified from holding the office of Director by virtue of any order from MCA/SEBI or any such statutory authority.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: